The Neurometabolic Function of the Dopamine–Aminotransferase System
Background/Objectives: The neurometabolic function is controlled by a complex multi-level physiological system that includes neurochemical, hormonal, immunological, sensory, and metabolic components. Functional disorders of monoamine systems are often detected in clinical practice together with meta...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/15/1/21 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587972723081216 |
|---|---|
| author | Sergey A. Apryatin |
| author_facet | Sergey A. Apryatin |
| author_sort | Sergey A. Apryatin |
| collection | DOAJ |
| description | Background/Objectives: The neurometabolic function is controlled by a complex multi-level physiological system that includes neurochemical, hormonal, immunological, sensory, and metabolic components. Functional disorders of monoamine systems are often detected in clinical practice together with metabolic dysfunctions. An important part of the mentioned pathological conditions are associated with disturbances in protein metabolism, some of the most important biomarkers which are aminotransferases and transcription factors that regulate and direct the most important metabolic reactions. Another important part of energy metabolism is the dopamine-mediated regulation of protein metabolism. Methods: The review describes research results into the dopamine-mediated mechanism of metabolic regulation in humans and animals. Particular attention is paid to the neurometabolic mechanisms of protein metabolism. Results: The dopamine–aminotransferase system of the energy metabolism regulation is a separate, independent, regulatory and diagnostically significant biochemical pathway controlled by the hormonal system, the key hormone is cortisol, the key neurotransmitter is dopamine, the key transcription factor is CREB, and the key regulatory enzymes are alanine aminotransferase, aspartate aminotransferase, and tyrosine aminotransferase. Conclusions: This review presents an original study describing the discovery of a new regulatory mechanism for neurometabolic physiological function in humans and animals. A key part of this mechanism is the dopamine–aminotransferase system. |
| format | Article |
| id | doaj-art-143c75021bf14bd28e1bb4e9a1654c7c |
| institution | Kabale University |
| issn | 2218-1989 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Metabolites |
| spelling | doaj-art-143c75021bf14bd28e1bb4e9a1654c7c2025-01-24T13:41:11ZengMDPI AGMetabolites2218-19892025-01-011512110.3390/metabo15010021The Neurometabolic Function of the Dopamine–Aminotransferase SystemSergey A. Apryatin0Institute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, RussiaBackground/Objectives: The neurometabolic function is controlled by a complex multi-level physiological system that includes neurochemical, hormonal, immunological, sensory, and metabolic components. Functional disorders of monoamine systems are often detected in clinical practice together with metabolic dysfunctions. An important part of the mentioned pathological conditions are associated with disturbances in protein metabolism, some of the most important biomarkers which are aminotransferases and transcription factors that regulate and direct the most important metabolic reactions. Another important part of energy metabolism is the dopamine-mediated regulation of protein metabolism. Methods: The review describes research results into the dopamine-mediated mechanism of metabolic regulation in humans and animals. Particular attention is paid to the neurometabolic mechanisms of protein metabolism. Results: The dopamine–aminotransferase system of the energy metabolism regulation is a separate, independent, regulatory and diagnostically significant biochemical pathway controlled by the hormonal system, the key hormone is cortisol, the key neurotransmitter is dopamine, the key transcription factor is CREB, and the key regulatory enzymes are alanine aminotransferase, aspartate aminotransferase, and tyrosine aminotransferase. Conclusions: This review presents an original study describing the discovery of a new regulatory mechanism for neurometabolic physiological function in humans and animals. A key part of this mechanism is the dopamine–aminotransferase system.https://www.mdpi.com/2218-1989/15/1/21neurometabolic functiondopamine–aminotransferase systemaspartate aminotransferasealanine aminotransferasetyrosine aminotransferaseDe Ritis ratio |
| spellingShingle | Sergey A. Apryatin The Neurometabolic Function of the Dopamine–Aminotransferase System Metabolites neurometabolic function dopamine–aminotransferase system aspartate aminotransferase alanine aminotransferase tyrosine aminotransferase De Ritis ratio |
| title | The Neurometabolic Function of the Dopamine–Aminotransferase System |
| title_full | The Neurometabolic Function of the Dopamine–Aminotransferase System |
| title_fullStr | The Neurometabolic Function of the Dopamine–Aminotransferase System |
| title_full_unstemmed | The Neurometabolic Function of the Dopamine–Aminotransferase System |
| title_short | The Neurometabolic Function of the Dopamine–Aminotransferase System |
| title_sort | neurometabolic function of the dopamine aminotransferase system |
| topic | neurometabolic function dopamine–aminotransferase system aspartate aminotransferase alanine aminotransferase tyrosine aminotransferase De Ritis ratio |
| url | https://www.mdpi.com/2218-1989/15/1/21 |
| work_keys_str_mv | AT sergeyaapryatin theneurometabolicfunctionofthedopamineaminotransferasesystem AT sergeyaapryatin neurometabolicfunctionofthedopamineaminotransferasesystem |